Overview

Catuaba refers to the bark of several Brazilian tree species traditionally used in folk medicine, with Trichilia catigua (family Meliaceae) being the most commonly identified botanical source in scientific literature. Other species marketed as catuaba include Erythroxylum vacciniifolium and Anemopaegma mirandum, leading to considerable taxonomic confusion in the supplement market. The bark has been used for centuries by the Tupi people of Brazil, primarily as a tonic for fatigue, sexual dysfunction, and nervous system support.

The phytochemical profile of Trichilia catigua bark includes flavalignans (cinchonains), flavan-3-ols (epicatechin and procyanidins), and tropane alkaloids. Research has identified several mechanisms underlying its reported effects, including dopaminergic modulation, antioxidant activity, and inhibition of monoamine reuptake. In vitro and animal studies have demonstrated neuroprotective effects against oxidative stress-induced neuronal damage, with particular relevance to age-related cognitive decline. One notable preclinical finding showed that catuaba extract protected hippocampal neurons from ischemia-induced cell death.

Despite its long history of traditional use and promising preclinical data, robust human clinical trials on catuaba remain limited. Small studies have reported improvements in mood, fatigue, and sexual function, but methodological limitations prevent definitive conclusions. Catuaba bark is widely available as a supplement in capsule, powder, and liquid extract forms and is a common ingredient in Brazilian herbal formulations. Consumers should note that the lack of standardization across products means that the species and phytochemical content may vary significantly between brands.

Mechanism of Action

Tropane Alkaloid & Flavonoid Pharmacology

Catuaba (Trichilia catigua, syn. Erythroxylum catuaba) bark contains a complex mixture of bioactive constituents including tropane alkaloids (catuabine A, B, C, D), flavalignans (cinchonain Ia, Ib, IIa, IIb), catechins, epicatechins, and procyanidins. Cinchonains are unique phenylpropanoid-flavonoid conjugates that contribute significantly to the extract's antioxidant and neuroprotective properties. The tropane alkaloids are structurally related to cocaine but lack dopamine transporter (DAT) binding affinity at physiological concentrations (PMID: 16198476).

Dopaminergic & Serotonergic Modulation

Catuaba bark extract modulates monoamine neurotransmission by inhibiting the reuptake of dopamine and serotonin in synaptosomal preparations, with IC50 values in the low micromolar range. This dual monoamine reuptake inhibition contributes to its traditional use as an aphrodisiac and mood enhancer. The extract also potentiates dopamine D1 receptor signaling in the prefrontal cortex, enhancing working memory and motivation-related behaviors in animal models (PMID: 15876432).

Neuroprotective & Anti-Excitotoxic Effects

Cinchonain Ib and related flavalignans protect hippocampal neurons against glutamate-induced excitotoxicity by reducing NMDA receptor-mediated calcium influx and suppressing mitochondrial membrane depolarization. Catuaba extract reduces oxidative stress in neuronal cells by scavenging hydroxyl radicals and peroxynitrite, and by upregulating superoxide dismutase (SOD) and catalase expression through Nrf2 pathway activation. These neuroprotective effects occur at concentrations as low as 10 microg/mL (PMID: 17582677).

Antimicrobial & Anti-Inflammatory Activity

Catuaba extract demonstrates antibacterial activity against E. coli, S. aureus, and P. aeruginosa through membrane disruption and inhibition of bacterial DNA gyrase. The procyanidin fraction inhibits COX-2 expression and PGE2 production in LPS-stimulated macrophages, contributing to anti-inflammatory effects (PMID: 19682570).

Reconstitution Calculator

Research

Safety Profile

Safety Profile: Catuaba (Trichilia catigua / Erythroxylum vacciniifolium)

Common Side Effects

• Mild gastrointestinal upset (nausea, stomach discomfort) in ~5-8% of users
• Insomnia or restlessness (due to mild stimulant properties)
• Headache
• Dry mouth
• Increased heart rate (mild, transient)

Serious Adverse Effects

• Cardiovascular stimulation: Tachycardia and palpitations reported at higher doses
• Hypertensive crisis: Theoretical concern when combined with other stimulants or MAOIs
• Hepatotoxicity: Limited data; isolated case reports of liver enzyme elevation with chronic use of bark extracts
• Serotonin-related effects: Some alkaloids in catuaba may have serotonergic activity; theoretical serotonin syndrome risk with concurrent serotonergic drugs
• Allergic reactions: Dermatitis and hypersensitivity reported rarely

Contraindications

• Known hypersensitivity to catuaba or related Trichilia/Erythroxylum species
• Uncontrolled hypertension or cardiovascular disease
• Anxiety disorders (stimulant properties may worsen symptoms)
• Concurrent MAOI therapy
• Insomnia (may exacerbate sleep disturbances)
• Hormone-sensitive conditions (breast cancer, uterine fibroids) due to potential estrogenic effects

Drug Interactions

• MAO inhibitors (phenelzine, tranylcypromine): Potential hypertensive crisis due to catecholaminergic alkaloids in catuaba
• SSRIs/SNRIs: Theoretical serotonin syndrome risk; monitor for agitation, hyperthermia, tremor
• Stimulants (caffeine, amphetamines): Additive cardiovascular stimulation
• Antihypertensives: May counteract blood pressure-lowering effects
• Anticoagulants: Some bark constituents may have mild antiplatelet activity
• Sedatives/Benzodiazepines: May partially counteract sedative effects
• PDE5 inhibitors (sildenafil): Additive vasodilatory effects; monitor for hypotension

Population-Specific Considerations

• Pregnancy: Contraindicated; no safety data available. Traditional use as a stimulant raises concern for fetal effects
• Lactation: Avoid; unknown excretion in breast milk and stimulant alkaloid content
• Pediatric: Not recommended; no safety or efficacy data in children
• Elderly: Use with caution; cardiovascular stimulant effects may be poorly tolerated
• Cardiovascular disease: Contraindicated in significant cardiac disease; may worsen arrhythmias or hypertension
• Note: Catuaba identity is complicated; multiple unrelated species are sold as "catuaba," each with different alkaloid profiles and safety concerns. Ensure species verification from supplier

Pharmacokinetic Profile